These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9283242)

  • 21. Immune-mediated disorders of cats.
    Werner LL; Gorman NT
    Vet Clin North Am Small Anim Pract; 1984 Sep; 14(5):1039-64. PubMed ID: 6149649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Veterinary autoimmunity: autoimmune diseases in domestic animals.
    Gershwin LJ
    Ann N Y Acad Sci; 2007 Aug; 1109():109-16. PubMed ID: 17785296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The estimation of circulating immune complexes, C3d, and anti-ds-DNA-antibody serum levels in the monitoring of therapeutic plasmapheresis in a patient with systemic lupus erythematosus. A case report.
    Krapf F; Manger B; Koch B; Kraulledat P; Kalden JR
    Clin Exp Rheumatol; 1985; 3(2):159-62. PubMed ID: 3874738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunosuppressive therapy in dogs and cats. Properties of drugs and their use in various immune-mediated diseases].
    Rieder J; Mischke R
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Apr; 46(2):105-118. PubMed ID: 29727898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of therapeutic plasmapheresis in a case of canine immune-mediated hemolytic anemia.
    Crump KL; Seshadri R
    J Vet Emerg Crit Care (San Antonio); 2009 Aug; 19(4):375-80. PubMed ID: 25164638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The therapeutic significance of plasmapheresis in immunologic diseases].
    Wegmüller E
    Schweiz Med Wochenschr; 1981 Mar; 111(13):443-9. PubMed ID: 6112794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive polysystemic immune-mediated disease in a dog.
    Werner LL; Bloomberg MS; Calderwood Mays MB; Ackerman N
    Vet Immunol Immunopathol; 1985 Jan; 8(1-2):183-92. PubMed ID: 3871988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmapheresis as adjuvant therapy for autoimmune hemolytic anemia in two dogs.
    Matus RE; Schrader LA; Leifer CE; Gordon BR; Hurvitz AI
    J Am Vet Med Assoc; 1985 Apr; 186(7):691-3. PubMed ID: 2580820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologically mediated thrombocytopenia in the dog.
    Wilkins RJ; Hurvitz AI; Dodds-Laffin WJ
    J Am Vet Med Assoc; 1973 Aug; 163(3):277-82. PubMed ID: 4737261
    [No Abstract]   [Full Text] [Related]  

  • 30. Current status in extracorporeal immunomodulation: immune disorders.
    Bosch T
    Artif Organs; 1996 Aug; 20(8):902-5. PubMed ID: 8853804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic plasmapheresis and plasma exchange.
    Patten E
    Crit Rev Clin Lab Sci; 1986; 23(2):147-75. PubMed ID: 3081298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience with large volume plasmapheresis in malignant paraproteinaemia and immune disorders.
    Isbister JP; Biggs JC; Penny R
    Aust N Z J Med; 1978 Apr; 8(2):154-64. PubMed ID: 98142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune-mediated disease in the old English sheepdog.
    Day MJ; Penhale WJ
    Res Vet Sci; 1992 Jul; 53(1):87-92. PubMed ID: 1410824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study on therapeutic plasmapheresis--mechanism of its efficacy, indication, and clinical application. a. Removal of antibodies and the clinical indications].
    Yokohari R; Uwatoko S; Kinoshita M
    Nihon Rinsho; 1984 Aug; 42(8):1855-60. PubMed ID: 6392608
    [No Abstract]   [Full Text] [Related]  

  • 35. Systemic lupus erythematosus with sensorineural hearing loss and improvement after plasmapheresis using the double filtration method.
    Kobayashi S; Fujishiro N; Sugiyama K
    Intern Med; 1992 Jun; 31(6):778-81. PubMed ID: 1392181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus.
    Jones JV; Cumming RH; Bacon PA; Evers J; Fraser ID; Bothamley J; Tribe CR; Davis P; Hughes GR
    Q J Med; 1979 Oct; 48(192):555-76. PubMed ID: 317156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canine systemic lupus erythematosus: new insights and their implications.
    Jones DR
    J Comp Pathol; 1993 Apr; 108(3):215-28. PubMed ID: 8315051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic plasmapheresis; present state and future aspects.
    Gurland HJ; Samtleben W; Blumenstein M
    Life Support Syst; 1983; 1(1):61-70. PubMed ID: 6379316
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of immunologic diseases using plasma separation. Proven and unproved indications].
    Schranz W; Kalden JR
    Fortschr Med; 1984 Apr; 102(16):458-62. PubMed ID: 6233210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in immunological therapy: plasma-exchange and immunosuppression.
    Pinching AJ
    Br J Anaesth; 1979 Jan; 51(1):21-8. PubMed ID: 162204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.